People with axial spondyloarthritis (axSpA) respond equally well to two types of medications that ease inflammation — tumor necrosis factor…
Margarida Maia PhD
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Margarida Maia PhD
Women with non-radiographic axial spondyloarthritis (axSpA) tend to be older and have longer, more active disease than men, a small…
A chronic inflammatory condition known as non-radiographic axial spondyloarthritis (axSpA) remained undetectable on X-ray for most people with active disease…
Anxiety and depression, but not resilience, were found to be linked to poorer overall health and functioning in people with…
Amgen’s Amjevita, the first biosimilar to Humira (adalimumab) to receive approval by the U.S. Food and Drug Administration,…
Alvotech has launched a Phase 1 clinical trial to test the safety and efficacy of AVT05, its biosimilar drug…
Health Canada has approved a high-concentration formulation of Hadlima (adalimumab-bwwd), a biosimilar to Humira (adalimumab), for treating…
Engaging in online yoga classes, or tele-yoga, may help people with ankylosing spondylitis (AS) relieve pain, overcome some functional…
People with ankylosis spondylitis (AS) may not be at an increased risk of developing severe symptoms of COVID-19, according…
Sudo Biosciences has secured $37 million in series A financing to back the development of TYK2 inhibitors as potential…